As the FDA's April 22nd deadline for many compounding pharmacies has passed and the May 22nd deadline arrives for small compounding pharmacies to stop producing semaglutide, many people in NJ on these medications are left wondering if the brand name medications Wegovy, Ozempic (semaglutide) and Zepbound (tirzepatide) are options for them moving forward
This research will help doctors better understand how the drug affects sexual function and whether these effects vary between men and women
N Engl J Med 268:277, 1963
Our team of experienced medical professionals, wellness experts, and endurance athletes is dedicated to providing personalized treatments that support your unique health journey
That is exactly what this medication class does
Jrgensens track record is marked by shepherding Novo through a boom in GLP-1 diabetes and obesity therapies Novos sales, profits, and market cap surged under his tenure